Lv51
980 积分 2021-06-08 加入
Safety and efficacy of antibody-drug conjugates plus immunotherapy in solid tumours: A systematic review and meta-analysis
9天前
已关闭
Brief report: Ivonescimab combined with etoposide plus carboplatin as first-line treatment for extensive-stage small-cell lung cancer: results of a phase Ib clinical trial
10天前
已完结
Targeting overexpressed antigens in glioblastoma via CAR T cells with computationally designed high-affinity protein binders
28天前
已完结
Computational design of protein binders that boost the antitumour efficacy of CAR T cells
28天前
已完结
From TCR fundamental research to innovative chimeric antigen receptor design
1个月前
已完结
FDA Approval Summary: Teclistamab – A Bispecific CD3 T-cell Engager for Patients with Relapsed or Refractory Multiple Myeloma
1个月前
已关闭
A CAR enhancer increases the activity and persistence of CAR T cells
1个月前
已完结
A trispecific antibody targeting HER2 and T cells inhibits breast cancer growth via CD4 cells
1个月前
已完结
Anti-CD19/CD8 bispecific T cell engager for the potential treatment of B cell malignancies
1个月前
已完结
IL-2Rα-biased agonist enhances antitumor immunity by invigorating tumor-infiltrating CD25+CD8+ T cells
2个月前
已完结
皖公网安备34019202002308
